Eight in 10 now survive skin cancer

July 22, 2013, Cancer Research UK

(Medical Xpress)—More than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to a new report from Cancer Research UK.

Ten year survival has reached 80 per cent in men and 90 per cent in women, compared to 38 per cent in men and 58 per cent in women 40 years ago. The improvements in are likely to be down to improvements in treatment, early and awareness of the symptoms.

Nearly 13,000 cases of melanoma are diagnosed each year in the UK, that's around 35 people every day.

Professor Richard Marais, director of the Cancer Research UK Paterson Institute for Cancer Research based at the University of Manchester, said: "Forty years ago, only around half of those diagnosed with were surviving, so eight out of 10 is a massive improvement. More and more people are beating skin cancer but we can't stop there and we need to develop better treatments for the two out of 10 where things don't look so good.

"Obviously we've come a long way in the fight against skin cancer and that's largely down to the of supporters who have funded research to help us to understand the disease better and find new ways of beating it. Research funded by Cancer Research UK has underpinned the development of new drugs like vemurafenib. Although these drugs do not cure skin cancers, they can give patients with advanced melanoma valuable extra months and show the progress we are making."

Dr Harpal Kumar, Cancer Research UK's chief executive, said: "Our research is revealing more about skin cancer: what causes it, how we can better prevent it and how we can develop targeted treatments to help more people beat the disease. By funding more research we can bring forward the day when even more people survive.

"Cancer Research UK research was behind the discovery that faults in a gene called BRAF contribute to over half of all cases of . Since then, our scientists have led efforts to develop drugs that target this gene.

"Skin cancer is one of the fastest rising cancers in the UK, which is likely to be down to our sunbathing habits and the introduction of cheap package holidays in previous decades. But the earlier cancer is detected, the easier it is to treat it and the more likely the treatment is to be successful. That's why it's important to get to know your skin and if you notice anything unusual, such as a change to a mole or a blemish that still hasn't healed after a few weeks, then get it checked out by your GP."

Explore further: Genome sequencing reveals mucosal melanoma's bullseye

More information: www.cancerresearchuk.org/cance … cerstats/types/skin/

Related Stories

Genome sequencing reveals mucosal melanoma's bullseye

June 7, 2013
(Medical Xpress)—Scientists may have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment, according to new research being published in the Journal of Pathology today ...

Early results show two drugs may be better than one to treat most deadly skin cancer

February 12, 2013
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.

Genetic screen finds new treatment targets for lung cancer

July 9, 2013
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research ...

Shape-shifting cells help skin cancer spread

June 10, 2013
(Medical Xpress)—Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body, according to new research published in Nature Cell Biology.

Diabetes treatment doubles skin cancer drug's effectiveness

April 2, 2012
Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.

Study suggests patients should be screened before receiving vemurafenib

August 14, 2012
Different genetic mistakes driving skin cancer may affect how patients respond to the drug vemurafenib, providing grounds to screen people with melanoma skin cancer before treatment, a new study by Cancer Research UK scientists ...

Recommended for you

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

Unhealthy lifestyle responsible for 45,000 predicted cases of bowel cancer in next decade

September 25, 2018
A UNSW study shows that a large proportion of bowel cancers in Australia are preventable by adopting a healthy lifestyle – particularly for men.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.